Biogen Breakout

We added Biogen (BIIB) to the Buy List this year, and I’m not sorry I added it, but the stock hasn’t done much for us. At least, not yet.

The stock has given us several false rallies, and it’s been up again recently. This time, however, could be different. I think traders would definitely take notice if BIIB could break $290 per share.

Posted by Eddy Elfenbein on May 31st, 2016 at 9:53 am

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.